Meeting
2023 ASCO Genitourinary Cancers Symposium
Stereotactic reirradiation for local prostate cancer recurrence: Mono-institutional experience of 108 patients.
Authors
Manon Baty
Centre Eugène Marquis, Rennes, France
Manon Baty , Joel Castelli , Khemara Gnep , Nolwenn Delaby , Romain Mathieu , Renaud de Crevoisier
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 365)
DOI
10.1200/JCO.2023.41.6_suppl.365
Abstract #
365
Poster Bd #
N3
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Long-term outcomes of stereotactic body radiotherapy for low- and intermediate-risk prostate adenocarcinoma: A multi-institutional consortium study.
First Author: Amar Upadhyaya Kishan
Poster
2017 Genitourinary Cancers Symposium
The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.
First Author: Stephane Gilles Guerif
Poster
2016 Genitourinary Cancers Symposium
Feasibility of salvage focal nodal SBRT or protracted elective nodal irradiation in 18F fluoro-choline PET based nodal failures from prostate cancer.
First Author: Alexis Lepinoy
Poster
2015 Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) reirradiation for recurrent pancreas cancer.
First Author: Rabia N Dagoglu